School of Health & Wellbeing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TB, United Kingdom.
School of Health & Wellbeing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TB, United Kingdom.
Public Health. 2024 Sep;234:47-57. doi: 10.1016/j.puhe.2024.05.015. Epub 2024 Jul 1.
We conducted a systematic review to assess the scope and effectiveness of interventions to improve human papilloma virus (HPV) vaccination in Africa from 2006 to 2021.
Systematic review.
Four databases (Medline, Embase, CINAHL and PsycINFO) were searched for articles published between 2006 and 2021. Articles were screened and included based on eligibility criteria using DistillerSR (Version 2.35). Data were extracted and reported using a narrative synthesis. A quality assessment was also conducted for each study using validated quality appraisal tools.
Out of 7603 articles identified by a systematic search, 18 articles met the inclusion criteria. Included studies comprised impact evaluation and cross-sectional studies published between 2012 and 2021 and conducted in eight African countries namely: Nigeria, Cameroon, South Africa, Kenya, Tanzania, Zambia, Mali, and Malawi. Study quality ranged from high to low quality. Interventions comprised fifteen educational and three multicomponent interventions. Out of thirteen impact evaluation studies (all educational interventions), twelve studies were effective in increasing HPV vaccine uptake and/or improving participants' knowledge, attitudes, and perceptions about the vaccine. Across five cross-sectional studies (two educational and three multicomponent interventions), HPV vaccine uptake rates ranged from 34% to 93.3%, with a consensus on safety and effectiveness in 67.9%-90.3% of participants post-intervention.
Educational and multicomponent interventions have been implemented to improve HPV vaccination in Africa. While educational interventions have proven effective at improving HPV vaccine uptake, a more diverse range of interventions with robust impact evaluation study designs are needed to strengthen the available evidence and improve vaccine uptake.
我们进行了一项系统评价,以评估 2006 年至 2021 年期间在非洲改善人乳头瘤病毒(HPV)疫苗接种的干预措施的范围和效果。
系统评价。
在 Medline、Embase、CINAHL 和 PsycINFO 四个数据库中搜索 2006 年至 2021 年期间发表的文章。使用 DistillerSR(版本 2.35)根据资格标准筛选和纳入文章。使用叙述性综合法提取和报告数据。还使用经过验证的质量评估工具对每项研究进行了质量评估。
通过系统搜索确定了 7603 篇文章,其中 18 篇符合纳入标准。纳入的研究包括影响评估和横断面研究,发表时间在 2012 年至 2021 年之间,在八个非洲国家进行,分别是:尼日利亚、喀麦隆、南非、肯尼亚、坦桑尼亚、赞比亚、马里和马拉维。研究质量从高质量到低质量不等。干预措施包括 15 项教育干预措施和 3 项多组分干预措施。在 13 项影响评估研究(均为教育干预措施)中,有 12 项研究在提高 HPV 疫苗接种率和/或提高参与者对疫苗的知识、态度和看法方面是有效的。在 5 项横断面研究(2 项教育干预和 3 项多组分干预)中,HPV 疫苗接种率从 34%到 93.3%不等,干预后 67.9%-90.3%的参与者对疫苗的安全性和有效性达成共识。
已经实施了教育和多组分干预措施来改善非洲的 HPV 疫苗接种。虽然教育干预措施已被证明可以有效提高 HPV 疫苗接种率,但需要更多不同类型的干预措施和更强大的影响评估研究设计,以加强现有证据并提高疫苗接种率。